Compare VCEL & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | CBZ |
|---|---|---|
| Founded | 1989 | 1987 |
| Country | United States | United States |
| Employees | N/A | 9500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 1996 |
| Metric | VCEL | CBZ |
|---|---|---|
| Price | $33.74 | $27.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $58.50 | $46.50 |
| AVG Volume (30 Days) | 718.0K | ★ 1.1M |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.00 | ★ 134.62 |
| EPS | 0.32 | ★ 1.83 |
| Revenue | $276,259,000.00 | ★ $922,003,000.00 |
| Revenue This Year | $19.10 | $3.92 |
| Revenue Next Year | $17.95 | $4.12 |
| P/E Ratio | $106.66 | ★ $15.09 |
| Revenue Growth | ★ 16.45 | 7.79 |
| 52 Week Low | $28.95 | $24.29 |
| 52 Week High | $45.97 | $80.65 |
| Indicator | VCEL | CBZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 47.86 |
| Support Level | $30.41 | $26.97 |
| Resistance Level | $34.34 | $32.09 |
| Average True Range (ATR) | 1.76 | 1.34 |
| MACD | 0.29 | 0.52 |
| Stochastic Oscillator | 83.11 | 97.50 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.